Home / Health / Cholesterol Drugs: Safer Choice for Some Stroke Risks
Cholesterol Drugs: Safer Choice for Some Stroke Risks
7 Nov
Summary
- PCSK9 inhibitors may be safer than statins for certain patients at risk of stroke.
- Statins slightly increase hemorrhagic stroke risk, especially at high doses.
- For patients with prior hemorrhagic stroke, statins quadruple the risk.
For millions of adults using statins to manage cholesterol, new research from UCLA indicates a crucial update regarding stroke risk. While statins are highly effective in lowering cholesterol and preventing ischemic strokes, a subset of patients may face an increased risk of hemorrhagic strokes, characterized by bleeding in the brain. This risk appears to be slightly elevated for all patients on statins, particularly at higher doses or in those with a history of ischemic stroke.
However, the study highlights a significant concern for individuals with a prior hemorrhagic stroke. In this group, statin use was found to quadruple the risk of future brain bleeds. Researchers suggest that PCSK9 inhibitors, a newer class of cholesterol-lowering drugs, could be a safer option for these patients. These inhibitors work through a distinct mechanism and may offer comparable or stronger cholesterol reduction with fewer adverse effects, providing a vital alternative for specific patient populations.
